This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liebana, E.
Right arrow Articles by Threlfall, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liebana, E.
Right arrow Articles by Threlfall, E. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2004, p. 4492, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4492.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

First Report of Salmonella Isolates with the DHA-1 AmpC ß-Lactamase in the United Kingdom


arrow
LETTER
 
Organisms expressing high levels of AmpC ß-lactamases are a major clinical concern, since they are resistant to all ß-lactams except for amdinocillin, cefepime, cefpirome, and carbapenems. Plasmid-borne AmpC ß-lactamases are increasingly reported among gram-negative bacteria worldwide. Some species of Enterobacter, Citrobacter, Morganella, and Hafnia produce chromosomal ß-lactamases copiously. AmpC enzymes encoded by genes that have escaped from these chromosomal locations are now plasmid encoded in a range of pathogens, including Salmonella (11).

More than 20 different plasmid-borne ampC genes have been identified (10). One of the encoded enzymes, DHA, was first described for Salmonella enterica serovar Enteritidis in Saudi Arabia in 1997 (3). A detailed study demonstrated that blaDHA-1 was located on an integron that originated from Morganella morganii (12). Plasmid-borne blaDHA genes have also been found in Klebsiella pneumoniae in France (2), Taiwan (13), and the United States (1, 7) and in Salmonella enterica serovar Montevideo in Korea (5).

The first reports of AmpC enzymes from humans in the United Kingdom were of blaBIL-1 for Escherichia coli in 1992 (9) and blaCMY-3 for K. pneumoniae in 1995 (4); also, blaBIL-1 was reported for E. coli in 1997 (8). Recently, we have reported the isolation of a blaCMY-2-positive Salmonella enterica serovar Bredeney isolate from an avian source (6). Most plasmid-mediated ampC genes identified up to 1998 in the Mediterranean area belonged to the groups CMY-2 to CMY-4 and LAT-1 to LAT-4, but recently other types, such as FOX-3 and FOX-4, have been reported (11). Globally, the majority of AmpC-like enzymes reported to date for Salmonella have been CMY-2.

During screening for antimicrobial resistance of 246,969 Salmonella isolates from humans in the United Kingdom between 1993 and 2003, we identified 104 isolates with resistance to ampicillin plus at least one of the following cephalosporins: cephalexin, cephradine, cefuroxime, ceftriaxone, and cefotaxime. This panel was subjected to further detailed phenotypic characterization, and 11 isolates presented a suggestive AmpC producer phenotype (AmpC enzymes, except ACC-1, confer resistance to cephamycins and to amoxicillin/clavulanate); these are currently being investigated. Two of these isolates, both of Salmonella enterica serotype Senftenberg, originating from patients hospitalized in London in 1996 (isolate A) and 1999 (isolate B), were positive for blaDHA in a multiplex AmpC-PCR (10). Subsequently, the blaDHA amplicon was sequenced, indicating 100% homology with blaDHA-1. The two isolates had different XbaI-pulsed-field gel electrophesis and plasmid profiles. Isolates A and B carried plasmids of approximately 98 and 99 MDa, respectively. Transferability of cefoxitin resistance was assessed by conjugation. Isolate A transferred a 98-MDa plasmid (codifying cefoxitin resistance) to an E. coli recipient. Attempts to transfer the plasmid from isolate B by conjugation failed. However, it was successfully transferred to ElectroMAX DH10B E. coli cells (Invitrogen) by electroporation. This represents the first report of blaDHA-1 in the United Kingdom and for serotype Senftenberg worldwide.

Laboratories should institute procedures for recognizing AmpC producers in cases where primary screening indicates resistance to expanded-spectrum cephalosporins. In addition, there should be routine surveillance to identify emerging genes which may present a threat to the treatment of invasive pathogens.


arrow
ACKNOWLEDGMENTS
 
This work was funded by the Department for Environment, Food and Rural Affairs, United Kingdom, project VM02136.


arrow
REFERENCES
 
    1
  1. Alvarez, M., J. H. Tran, N. Chow, and G. A. Jacoby. 2004. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob. Agents Chemother. 48:533-537.[Abstract/Free Full Text]
    2. 2
  2. Fortineau, N., L. Poirel, and P. Nordmann. 2001. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:207-210.[Abstract/Free Full Text]
    3. 3
  3. Gaillot, O., C. Clement, M. Simonet, and A. Philippon. 1997. Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella Enteritidis. J. Antimicrob. Chemother. 39:85-87.[Abstract/Free Full Text]
    4. 4
  4. Jenks, P. J., Y. M. Hu, F. Danel, S. Mehtar, and D. M. Livermore. 1995. Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK. J. Antimicrob. Chemother. 35:235-236.[Free Full Text]
    5. 5
  5. Kim, J. Y., Y. J. Park, S. O. Lee, W. Song, S. H. Jeong, Y. A. Yoo, and K. Y. Lee. 2004. Case report: bacteremia due to Salmonella enterica serotype Montevideo producing plasmid-mediated AmpC beta-lactamase (DHA-1). Ann. Clin. Lab. Sci. 34:214-217.[Abstract/Free Full Text]
    6. 6
  6. Liebana, E., M. Gibbs, C. Clouting, L. Barker, F. A. Clifton-Hadley, E. Pleydell, B. Abdalhamid, N. D. Hanson, L. Martin, C. Poppe, and R. H. Davies. 2004. Characterisation of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom. Microb. Drug Resist. 10:1-9.[CrossRef][Medline]
    7. 7
  7. Moland, E. S., J. A. Black, J. Ourada, M. D. Reisbig, N. D. Hanson, and K. S. Thomson. 2002. Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob. Agents Chemother. 46:3837-3842.[Abstract/Free Full Text]
    8. 8
  8. M'Zali, F. H., J. Heritage, D. M. Gascoyne-Binzi, M. Denton, N. J. Todd, and P. M. Hawkey. 1997. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. J. Antimicrob. Chemother. 40:823-831.[Abstract/Free Full Text]
    9. 9
  9. Payne, D. J., N. Woodford, and S. G. Amyes. 1992. Characterization of the plasmid mediated beta-lactamase BIL-1. J. Antimicrob. Chemother. 30:119-127.[Abstract/Free Full Text]
    10. 10
  10. Perez-Perez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.[Abstract/Free Full Text]
    11. 11
  11. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type beta-lactamases. Antimicrob. Agents Chemother. 46:1-11.[Free Full Text]
    12. 12
  12. Verdet, C., G. Arlet, G. Barnaud, P. H. Lagrange, and A. Philippon. 2000. A novel integron in Salmonella enterica serovar Enteritidis, carrying the blaDHA-1 gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob. Agents Chemother. 44:222-225.[Abstract/Free Full Text]
    13. 13
  13. Yan, J. J., W. C. Ko, Y. C. Jung, C. L. Chuang, and J. J. Wu. 2002. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan. J. Clin. Microbiol. 40:3121-3126.[Abstract/Free Full Text]
E. Liebana*
M. Batchelor
F. A. Clifton-Hadley
R. H. Davies
Department of Food and Environmental Safety
Veterinary Laboratories Agency
Surrey KT153NB, United Kingdom

K. L. Hopkins
E. J. Threlfall
Laboratory of Enteric Pathogens
Central Public Health Laboratories
London NW95HT, United Kingdom

* Phone: 44-1932-840782, Fax: 44-1932-357595, E-mail: e.liebana{at}vla.defra.gsi.gov.uk

Antimicrobial Agents and Chemotherapy, November 2004, p. 4492, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4492.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Woodford, N., Reddy, S., Fagan, E. J., Hill, R. L. R., Hopkins, K. L., Kaufmann, M. E., Kistler, J., Palepou, M.-F. I., Pike, R., Ward, M. E., Cheesbrough, J., Livermore, D. M. (2007). Wide geographic spread of diverse acquired AmpC {beta}-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 59: 102-105 [Abstract] [Full Text]  
  • Power, P., Galleni, M., Ayala, J. A., Gutkind, G. (2006). Biochemical and Molecular Characterization of Three New Variants of AmpC {beta}-Lactamases from Morganella morganii. Antimicrob. Agents Chemother. 50: 962-967 [Abstract] [Full Text]  
  • Verdet, C., Benzerara, Y., Gautier, V., Adam, O., Ould-Hocine, Z., Arlet, G. (2006). Emergence of DHA-1-Producing Klebsiella spp. in the Parisian Region: Genetic Organization of the ampC and ampR Genes Originating from Morganella morganii. Antimicrob. Agents Chemother. 50: 607-617 [Abstract] [Full Text]  
  • Yates, C., Amyes, S. (2005). Extended-spectrum {beta}-lactamases in non-typhoidal Salmonella spp. isolated in the UK are now a reality: why the late arrival?. J Antimicrob Chemother 56: 262-264 [Abstract] [Full Text]  
  • Batchelor, M., Hopkins, K. L., Threlfall, E. J., Clifton-Hadley, F. A., Stallwood, A. D., Davies, R. H., Liebana, E. (2005). Characterization of AmpC-Mediated Resistance in Clinical Salmonella Isolates Recovered from Humans during the Period 1992 to 2003 in England and Wales. J. Clin. Microbiol. 43: 2261-2265 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liebana, E.
Right arrow Articles by Threlfall, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liebana, E.
Right arrow Articles by Threlfall, E. J.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»